Fundraising Fox

Myolex

Brookline, US · Founded 2009 · 8 employees on LinkedIn · 1 known investors

Myolex develops a portable, non-invasive muscle assessment device based on electrical impedance myography (EIM) that measures single-muscle composition and structure to aid diagnosis, prognosis, and treatment monitoring of neuromuscular and musculoskeletal diseases such as ALS. It serves clinicians, researchers, and pharmaceutical companies, with applications in clinical trials and at-home patient monitoring.

Digital HealthHardwareMedical Devices

Founders & leadership

Myolex was founded in 2009 by Seward Rutkove.

SRSeward Rutkove
Seward RutkoveCo-founder

Investors · 1

Nautilus Ventures Management Company (Us), LlcPalo Alto

Competitors · 2

by search overlap
Hinge Health15 shared keywordsHinge Health builds a digital healthcare platform designed to help individuals manage musculoskeletal health and related conditions. The company serves health plans, employers, and individuals seeking alternative healthcare approaches.
Ubie13 shared keywordsUbie provides a free AI-powered symptom checker that generates a personalized report on possible causes of a user's symptoms and guidance on when to see a doctor, based on a short questionnaire developed with doctors. The consumer-facing digital health service operates in Japan, the United States, and other countries.

Companies competing with Myolex for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 14 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2022$1.8M
National Institutes of Health (NIH)National Institutes of HealthPhase II2021$1.7M
National Institutes of Health (NIH)National Institutes of HealthPhase II2019$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase II2018$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2018$225K
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$225K
National Institutes of Health (NIH)National Institutes of HealthPhase I2017$150K
National Institutes of Health (NIH)National Institutes of HealthPhase II2014$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2014$225K
National Institutes of Health (NIH)National Institutes of HealthPhase II2013$1.1M
National Institutes of Health (NIH)National Institutes of HealthPhase II2012$1.7M
National Institutes of Health (NIH)National Institutes of HealthPhase I2011$289.9K
National Science FoundationPhase I2011$150K
National Institutes of Health (NIH)National Institutes of HealthPhase I2010$220.6K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Myolex Awarded NIH Grant of up to $2.2M to Advance a Valuable Proxy for MRI in Assessing Skeletal Muscle Healthprnewswire.com · Aug 2024

Frequently asked questions

What does Myolex do?
Myolex develops a portable, non-invasive muscle assessment device based on electrical impedance myography (EIM) that measures single-muscle composition and structure to aid diagnosis, prognosis, and treatment monitoring of neuromuscular and musculoskeletal diseases such as ALS. It serves clinicians, researchers, and pharmaceutical companies, with applications in clinical trials and at-home patient monitoring.
Who founded Myolex?
Myolex was founded by Seward Rutkove in 2009.
Who are Myolex's investors?
Myolex's investors include Nautilus Ventures Management Company (Us), Llc.
Where is Myolex headquartered?
Myolex is headquartered in Brookline, US.